Search All UT System Experts

Dual phosphoinositide 3-kinase/mammalian target of rapamycin blockade is an effective radiosensitizing strategy for the treatment of non-small cell lung cancer harboring K-RAS mutations

Georgia Konstantinidou, Erik A. Bey, Andrea Rabellino, Katja Schuster, Michael S. Maira, Adi F. Gazdar, Augusto Amici, David A. Boothman, Pier Paolo Scaglioni

Research output: Contribution to journal › Article › peer-review

133 Scopus citations

Fingerprint

Dive into the research topics of 'Dual phosphoinositide 3-kinase/mammalian target of rapamycin blockade is an effective radiosensitizing strategy for the treatment of non-small cell lung cancer harboring K-RAS mutations'. Together they form a unique fingerprint.

Medicine & Life Sciences